Minodronic acid

Minodronic acid
Minodronic acid
Identifiers
CAS number 180064-38-4 YesY, 155648-60-5 (hydrate) YesY
PubChem 130956
ChemSpider 115805 YesY
Jmol-3D images Image 1
Properties
Molecular formula C9H12N2O7P2
Molar mass 322.15 g mol−1
 N acid (verify) (what is: YesY/N?)
Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa)
Infobox references

Minodronic acid is a third-generation bisphosphonate drug. It is approved for use in Japan for the treatment of osteoporosis.[1] Its mechanism of action involves inhibition of farnesyl pyrophosphate synthase activity.[2]

References

  1. ^ Shridhar Hegde and Michelle Schmidt (2009). "To Market, To Market - 2009. 16. Minodronic acid". Annual Reports in Medicinal Chemistry 45: 509–510. 
  2. ^ Sorbera, L.A.; Castañer, J.; Leeson, P.A. (2002). "Minodronic Acid". Drugs of the Future 27 (10): 935–941. doi:10.1358/dof.2002.027.10.701186.